Moleculin Biotech, Inc. · NASDAQ:MBRX
Klemp Walter V exercised options for 510 Moleculin Biotech, Inc. shares (Form 4)
Traded Jun 20 to Jun 22, 2026 · Filed Jun 24, 2026
From Jun 20 to Jun 22, 2026, Klemp Walter V (Director, CEO and President) exercised options for 510 Moleculin Biotech, Inc. shares, leaving 31,007 shares. Filed Jun 24, 2026 (Form 4).
- Options exercised
- 510 shares
- Holding after
- 31,007 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 20, 2026 | Common Stock | Option exercise | 150 | 30,765 | Direct | |
| Jun 20, 2026 | Common Stock | Shares withheld for tax | 37 | US$2.88 | 30,728 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 360 | 31,088 | Direct | |
| Jun 22, 2026 | Common Stock | Shares withheld for tax | 88 | US$3.12 | 31,007 | Direct |
Source
Related
- Moleculin Biotech, Inc.
- Klemp Walter V
- Moleculin Biotech, Inc. shareholders
- Form 4 · Klemp Walter V · Oct 16, 2026
- Form 4 · Klemp Walter V · Aug 5, 2026
- Form 4 · Foster Jonathan P. · Oct 16, 2026
- Schedule 13D · Foster Jonathan P. · Aug 25, 2026
- Schedule 13D · Klemp Walter V · Aug 25, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 10, 2026
- Schedule 13G · Mitchell P. Kopin · Aug 6, 2026